Literature DB >> 14645634

Therapeutic options for laryngeal cancer.

Everett E Vokes1, Kerstin M Stenson.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 14645634     DOI： 10.1056/NEJMp038171

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Tumor necrosis factor superfamily member 13 is a novel biomarker for diagnosis and prognosis and promotes cancer cell proliferation in laryngeal squamous cell carcinoma.

Authors:  Ru Wang; Yichao Guo; Hongzhi Ma; Lin Feng; Qi Wang; Xiaohong Chen; Meng Lian; Haizhou Wang; Jugao Fang
Journal:  Tumour Biol       Date:  2015-09-23

2.  Clinical significance of ADAM10 expression in laryngeal carcinoma.

Authors:  Bo You; Miao Gu; Xiaolei Cao; Xingyu Li; Si Shi; Ying Shan; Yiwen You
Journal:  Oncol Lett       Date:  2016-12-28       Impact factor: 2.967

3.  CXCR4 silencing inhibits invasion and migration of human laryngeal cancer Hep-2 cells.

Authors:  Juntao Niu; Yongwang Huang; Lun Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

4.  DIRC3 and near NABP1 genetic polymorphisms are associated laryngeal squamous cell carcinoma patient survival.

Authors:  Zhen Shen; Wanli Ren; Yanxia Bai; Zhengshuai Chen; Jingjie Li; Bin Li; Tianbo Jin; Peilong Cao; Yuan Shao
Journal:  Oncotarget       Date:  2016-11-29

5.  Inflammation and cancer: role of annexin A1 and FPR2/ALX in proliferation and metastasis in human laryngeal squamous cell carcinoma.

Authors:  Thaís Santana Gastardelo; Bianca Rodrigues Cunha; Luís Sérgio Raposo; José Victor Maniglia; Patrícia Maluf Cury; Flávia Cristina Rodrigues Lisoni; Eloiza Helena Tajara; Sonia Maria Oliani
Journal:  PLoS One       Date:  2014-12-09       Impact factor: 3.240

6.  Prognostic factors of patients with initially diagnosed T1a glottic cancer: Novel nomograms and a propensity-score matched cohort analysis.

Authors:  Meng-Si Luo; Guan-Jiang Huang; Hong-Bing Liu
Journal:  Medicine (Baltimore)       Date:  2020-11-06       Impact factor: 1.817
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.